Scientific article
English

CCR5 Mutations Distinguish N-Terminal Modifications of RANTES (CCL5) with Agonist versus Antagonist Activity

Published in

Journal of virology, vol. 86, no. 18, p. 10218-10220

Publication date

2012

Abstract

CCR5 is the major HIV-1 entry coreceptor. RANTES/CCL5 analogs are more potent inhibitors of infection than native chemokines; one class activates and internalizes CCR5, one neither activates nor internalizes, and a third partially internalizes without activation. Here we show that mutations in CCR5 transmembrane domains differentially impact the activity of these three inhibitor classes, suggesting that the transmembrane region of CCR5, a key interaction site for inhibitors, is a sensitive molecular switch, modulating receptor activity.

Citation (ISO format)

CHOI, Won-Tak et al. CCR5 Mutations Distinguish N-Terminal Modifications of RANTES (CCL5) with Agonist versus Antagonist Activity. In: Journal of virology, 2012, vol. 86, n° 18, p. 10218–10220. doi: 10.1128/JVI.00353-12

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

0022-538X
647views
0downloads

Technical informations

Creation

10/10/2012 16:11:00

First validation

10/10/2012 16:11:00

Update

08/01/2025 10:34:24

Status update

08/01/2025 10:34:24

Last indexation

08/01/2025 10:36:12
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated